| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | €84,2387 | +3,84% | €1,23B | €128,95K | |
TMP Tompkins Financial Corporation | €84,1255 | -2,12% | €1,23B | €21,78K | |
BRUN Boost Run Inc. Class A Common Stock | €16,6284 | -3,66% | €1,23B | €1,40M | |
TWFG TWFG, Inc. Common Stock | €23,3899 | +1,87% | €1,23B | €65,86K | |
PCT PureCycle Technologies, Inc. Common stock | €6,2290 | +5,60% | €1,23B | €1,24M | |
REX REX American Resources Corp. | €37,7899 | -0,10% | €1,23B | €26,75K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | €6,7392 | -5,87% | €1,23B | €30,16K | |
BTT BlackRock Municipal 2030 Target Term Trust | €19,3944 | +0,13% | €1,23B | €8,33K | |
ADNT Adient plc Ordinary Shares | €17,0708 | +2,21% | €1,23B | €122,26K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | €23,1412 | -0,04% | €1,23B | €1,57M | |
| €32,0753 | -0,40% | €1,22B | €402,29K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | €2,4779 | -7,37% | €1,22B | €330,07K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | €14,4335 | -1,03% | €1,22B | €51,45K | |
REPL Replimune Group, Inc. | €12,7864 | -4,28% | €1,22B | €1,59M | |
HCSG Healthcare Services Group | €19,8308 | +5,42% | €1,22B | €218,39K | |
